The latest Investing Matters Podcast episode featuring financial educator and author Jared Dillian has been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSabre Insur Regulatory News (SBRE)

Share Price Information for Sabre Insur (SBRE)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 155.20
Bid: 153.80
Ask: 154.40
Change: -0.20 (-0.13%)
Spread: 0.60 (0.39%)
Open: 155.40
High: 155.40
Low: 153.60
Prev. Close: 155.40
SBRE Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Director/PDMR Shareholding

6 Apr 2023 12:28

RNS Number : 6650V
Sabre Insurance Group PLC
06 April 2023
 

6 April 2023

 

Sabre Insurance Group plc ('Sabre' or the 'Company')

Notification of transactions of Directors, Persons Discharging Managerial Responsibility ('PDMRs') or Connected Persons

 

The Company announces that on 6 April 2023 the following directors and PDMRs of the Company were, subject to the rules of the Sabre 2017 Long Term Incentive Plan ('LTIP'), each granted a conditional award (the 'LTIP Award') of ordinary shares of £0.001 in the Company as detailed below:

 

Name

Position

Number of shares subject to award

Geoff Carter

Chief Executive Officer

314,371

Anneka Kingan

Chief Risk and Officer and Company Secretary

121,197

Trevor Webb

Claims Director

195,745

Adam Westwood

Chief Financial Officer

153,587

Matt Wright

Chief Actuary

126,161

 

The awards will vest on the third anniversary of their grant, and are subject to an additional retention period of two years, commencing on the awards' vesting date.

 

The vesting of the awards will be subject to the following underpins:

that the solvency coverage ratio of the Group (being the ratio of the Group's Solvency II net assets to its Solvency Capital Requirement, calculated before the final dividend is paid, expressed as a percentage) is maintained in excess of 140% over the LTIP Period

that the Group has achieved a Return On Tangible Equity (being the ratio of the Group's adjusted profit after tax to its average tangible equity, expressed as a percentage) in excess of 10% for each full reporting period which falls within the LTIP Period

that there has been no material intervention by a regulatory authority either initiated during the LTIP Period or related to it, that results in a Group Member being required by the relevant authority to undertake actions or remedial measures

overall Committee discretion

 

This notification is made pursuant to Article 19 of the EU Market Abuse Regulation.

 

Additional Information:

Anneka Kingan - Company Secretary

Anneka.kingan@sabre.co.uk

 

 

 

PDMR transaction notification

 

1

 

Details of the person discharging managerial responsibilities / person closely associated

 

a)

 

Name

 

Geoff Carter

2

 

Reason for the notification

 

a)

 

Position/status

 

Chief Executive Officer

b)

 

Initial notification /Amendment

Initial notification

3

 

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

 

a)

 

Name

 

Sabre Insurance Group plc

b)

 

LEI

 

2138006RXRQ8P8VKGV98

4

 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

 

a)

 

Description of the financial instrument, type of instrument

A non-transferable conditional award of ordinary shares in the Company under the Sabre 2017 Long-Term Incentive Plan. No consideration will be paid by the PDMR on the grant or vesting of the conditional award.

Identification code

GB00BYWVDP49

b)

 

Nature of the transaction

 

 

Grant of conditional award

c)

 

Price(s) and volume(s)

 

Price per share

Volume

£1.154

314,371

d)

Aggregated Information

Volume

Price

 

Volume

Price per share

314,371

£1.154

 

e)

Date of transaction

6 April 2023

f)

Place of transaction

London Stock Exchange (XLON)

 

 

 

 

 

PDMR transaction notification

 

1

 

Details of the person discharging managerial responsibilities / person closely associated

 

a)

 

Name

 

Anneka Kingan

2

 

Reason for the notification

 

a)

 

Position/status

 

Chief Risk Officer and Company Secretary

b)

 

Initial notification /Amendment

Initial notification

3

 

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

 

a)

 

Name

 

Sabre Insurance Group plc

b)

 

LEI

 

2138006RXRQ8P8VKGV98

4

 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

 

a)

 

Description of the financial instrument, type of instrument

A non-transferable conditional award of ordinary shares in the Company under the Sabre 2017 Long-Term Incentive Plan. No consideration will be paid by the PDMR on the grant or vesting of the conditional award.

Identification code

GB00BYWVDP49

b)

 

Nature of the transaction

 

 

Grant of conditional award

c)

 

Price(s) and volume(s)

 

Price per share

Volume

£1.154

121,197

d)

Aggregated Information

Volume

Price

 

Volume

Price per share

121,197

£1.154

 

e)

Date of transaction

6 April 2023

f)

Place of transaction

London Stock Exchange (XLON)

 

 

PDMR transaction notification

 

1

 

Details of the person discharging managerial responsibilities / person closely associated

 

a)

 

Name

 

Trevor Webb

2

 

Reason for the notification

 

a)

 

Position/status

 

Claims Director

b)

 

Initial notification /Amendment

Initial notification

3

 

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

 

a)

 

Name

 

Sabre Insurance Group plc

b)

 

LEI

 

2138006RXRQ8P8VKGV98

4

 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

 

a)

 

Description of the financial instrument, type of instrument

A non-transferable conditional award of ordinary shares in the Company under the Sabre 2017 Long-Term Incentive Plan. No consideration will be paid by the PDMR on the grant or vesting of the conditional award.

Identification code

GB00BYWVDP49

b)

 

Nature of the transaction

 

 

Grant of conditional award

c)

 

Price(s) and volume(s)

 

Price per share

Volume

£1.154

195,745

d)

Aggregated Information

Volume

Price

 

Volume

Price per share

195,745

£1.154

 

e)

Date of transaction

6 April 2023

f)

Place of transaction

London Stock Exchange (XLON)

 

 

PDMR transaction notification

 

1

 

Details of the person discharging managerial responsibilities / person closely associated

 

a)

 

Name

 

Adam Westwood

2

 

Reason for the notification

 

a)

 

Position/status

 

Chief Financial Officer

b)

 

Initial notification /Amendment

Initial notification

3

 

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

 

a)

 

Name

 

Sabre Insurance Group plc

b)

 

LEI

 

2138006RXRQ8P8VKGV98

4

 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

 

a)

 

Description of the financial instrument, type of instrument

A non-transferable conditional award of ordinary shares in the Company under the Sabre 2017 Long-Term Incentive Plan. No consideration will be paid by the PDMR on the grant or vesting of the conditional award.

Identification code

GB00BYWVDP49

b)

 

Nature of the transaction

 

 

Grant of conditional award

c)

 

Price(s) and volume(s)

 

Price per share

Volume

£1.154

153,587

d)

Aggregated Information

Volume

Price

 

Volume

Price per share

153,587

£1.154

 

e)

Date of transaction

6 April 2023

f)

Place of transaction

London Stock Exchange (XLON)

 

 

 

PDMR transaction notification

 

1

 

Details of the person discharging managerial responsibilities / person closely associated

 

a)

 

Name

 

Matt Wright

2

 

Reason for the notification

 

a)

 

Position/status

 

Chief Actuary

b)

 

Initial notification /Amendment

Initial notification

3

 

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

 

a)

 

Name

 

Sabre Insurance Group plc

b)

 

LEI

 

2138006RXRQ8P8VKGV98

4

 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

 

a)

 

Description of the financial instrument, type of instrument

A non-transferable conditional award of ordinary shares in the Company under the Sabre 2017 Long-Term Incentive Plan. No consideration will be paid by the PDMR on the grant or vesting of the conditional award.

Identification code

GB00BYWVDP49

b)

 

Nature of the transaction

 

 

Grant of conditional award

c)

 

Price(s) and volume(s)

 

Price per share

Volume

£1.154

126,161

d)

Aggregated Information

Volume

Price

 

Volume

Price per share

126,161

£1.154

 

e)

Date of transaction

6 April 2023

f)

Place of transaction

London Stock Exchange (XLON)

 

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DSHFQLFBXZLLBBX
Date   Source Headline
13th Feb 20231:51 pmRNSDirector/PDMR Shareholding
13th Jan 20231:52 pmRNSHolding(s) in Company
11th Jan 20234:00 pmRNSDirector/PDMR Shareholding
19th Dec 20222:31 pmRNSHolding(s) in Company
13th Dec 20221:20 pmRNSDirector/PDMR Shareholding
11th Nov 202212:09 pmRNSDirector/PDMR Shareholding
7th Nov 20221:47 pmRNSHolding(s) in Company
13th Oct 20227:00 amRNSTrading Update
11th Oct 20223:20 pmRNSDirector/PDMR Shareholding
28th Sep 20222:11 pmRNSDirector/PDMR Shareholding
23rd Sep 202211:47 amRNSDirector/PDMR Shareholding
13th Sep 20223:57 pmRNSDirector/PDMR Shareholding
26th Aug 202210:45 amRNSDirectorate Change
11th Aug 20223:25 pmRNSDirector/PDMR Shareholding
10th Aug 20229:08 amRNSHolding(s) in Company
1st Aug 20229:19 amRNSDirector/PDMR Shareholding
28th Jul 20222:34 pmRNSHolding(s) in Company
28th Jul 20229:14 amRNSHolding(s) in Company
27th Jul 20221:35 pmRNSDirector/PDMR Shareholding
27th Jul 20229:26 amRNSHolding(s) in Company
27th Jul 20229:19 amRNSDirector/PDMR Shareholding
26th Jul 202212:19 pmRNSDirector/PDMR Shareholding
26th Jul 202212:06 pmRNSDirector/PDMR Shareholding
26th Jul 20227:00 amRNSHalf-Year Report 2022
18th Jul 20221:07 pmRNSHolding(s) in Company
14th Jul 20227:00 amRNSHalf-Year 2022 Trading Update
12th Jul 202212:49 pmRNSDirector/PDMR Shareholding
1st Jul 20229:55 amRNSHolding(s) in Company
14th Jun 202211:58 amRNSDirector/PDMR Shareholding
13th Jun 20223:54 pmRNSDirector/PDMR Shareholding
6th Jun 20223:15 pmRNSDirector/PDMR Shareholding
6th Jun 20223:06 pmRNSDirector/PDMR Shareholding
25th May 20221:24 pmRNSResult of AGM
25th May 20227:00 amRNSTrading Update
19th May 20221:45 pmRNSHolding(s) in Company
13th May 20222:24 pmRNSHolding(s) in Company
11th May 20222:27 pmRNSDirector/PDMR Shareholding
26th Apr 20223:17 pmRNSDirector/PDMR Shareholding
26th Apr 20222:21 pmRNSDirector/PDMR Shareholding
14th Apr 20229:01 amRNSHolding(s) in Company
13th Apr 20224:18 pmRNSNotice of AGM
12th Apr 20223:34 pmRNSDirector/PDMR Shareholding
8th Apr 20228:42 amRNSDirector/PDMR Shareholding
1st Apr 20227:13 amRNSDividend Declaration
1st Apr 20227:00 amRNSBoard Appointment
22nd Mar 20227:00 amRNSFinal Results
14th Mar 20221:22 pmRNSDirector Declaration
11th Mar 20221:50 pmRNSDirector/PDMR Shareholding
22nd Feb 20227:00 amRNSNotice of Results
21st Feb 202212:31 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.